Paar, V.,
Jirak, P.,
Larbig, R.,
Zagidullin, N.S.,
Brandt, M.C.,
Lichtenauer, M.,
Hoppe, U.C.,
Motloch, L.J. (2019) arrhythmia
therapy. Furthermore, we discuss various promising cellular and mitochondrial
targetsWANG, K.,
LIU, H.,
LIU, J.,
WANG, X.,
TENG, L.,
ZHANG, J.,
CHEN, X.,
WANG, N.,
ZHONG, Y.,
HOU, X.,
JIANG, H.,
ZHANG, X.,
ZHAO, S.,
LIU, Y.,
YAO, Y.,
WANG, J.,
QU, Y.,
PENG, F.,
BEYLERLI, O.,
LIAO, X. (2019) that
targeting amino acid metabolism such as methionine deprivation/IL1RN related gene
therapy may offer novel
Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQImportance of Novel Intraperitoneal
Therapy of NF-kappa B Inhibitor DHMEQ
and resistance to
therapy. Prostate
cancer patients often have long time periods between curative intent surgery